On June 21, 2023, Nicholas Haft resigned from the Board of Directors of Finch Therapeutics Group, Inc., effective as of June 23, 2023. Mr. Haftâs decision to resign as a member of the Board was not the result of any disagreement between Mr. Haft and the Company on any matters relating to the Companyâs operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | -1.48% | +37.54% | -63.16% |
May. 30 | Finch Therapeutics Group, Inc.(NasdaqGS:FNCH) dropped from S&P TMI Index | CI |
May. 27 | Finch Therapeutics Group, Inc.(OTCPK:FNCH) dropped from NASDAQ Composite Index | CI |
1st Jan change | Capi. | |
---|---|---|
-63.16% | 2.14M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- FNCH Stock
- News Finch Therapeutics Group, Inc.
- Finch Therapeutics Group, Inc. Announces Resignation of Nicholas Haft as Member of Board